Skip to Content
Merck
CN
All Photos(1)

Documents

V900548

Sigma-Aldrich

TWEEN® 20

Vetec™, reagent grade, 40%

Synonym(s):

Polyethylene glycol sorbitan monolaurate, Polyoxyethylenesorbitan monolaurate

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

CAS Number:
9005-64-5
MDL number:
MFCD00165986
UNSPSC Code:
12161900

grade

reagent grade

description

non-ionic detergent

product line

Vetec™

mol wt

~1228

concentration

40%

technique(s)

DNA extraction: suitable
RNA extraction: suitable
cell culture | mammalian: suitable
protein purification: suitable

refractive index

n20/D 1.468 (lit.)

density

1.095 g/mL at 25 °C (lit.)

SMILES string

CCCCCCCCCCCC(=O)OCCOCC(C1C(C(CO1)OCCO)OCCO)OCCO

InChI

1S/C26H50O10/c1-2-3-4-5-6-7-8-9-10-11-24(30)34-19-18-31-20-22(32-15-12-27)26-25(35-17-14-29)23(21-36-26)33-16-13-28/h22-23,25-29H,2-21H2,1H3

InChI key

HMFKFHLTUCJZJO-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Application

Non-ionic detergent

Legal Information

TWEEN is a registered trademark of Croda International PLC
Vetec is a trademark of Merck KGaA, Darmstadt, Germany

WGK

WGK 1

Flash Point(F)

>298.4 °F

Flash Point(C)

> 148 °C

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Deng Pan et al.
Experimental brain research, 238(4), 1085-1095 (2020-03-28)
Ghrelin is an orexigenic agonist that acts directly on neurons in the hypothalamus, controlling appetite and energy balance. Although its role in appetite-associated neurons has been described, the relationship between peripheral ghrelin stimulation and oxytocin expression in the paraventricular nucleus
Daniel C Zielinski et al.
Nature communications, 6, 7101-7101 (2015-06-10)
Drug side effects cause a significant clinical and economic burden. However, mechanisms of drug action underlying side effect pathogenesis remain largely unknown. Here, we integrate pharmacogenomic and clinical data with a human metabolic network and find that non-pharmacokinetic metabolic pathways
Julie Beegle et al.
Stem cells (Dayton, Ohio), 33(6), 1818-1828 (2015-02-24)
Mesenchymal stem cells/multipotent stromal cells (MSCs) are promising therapeutics for a variety of conditions. However, after transplantation, cell retention remains extremely challenging. Given that many hypoxic signals are transitory and that the therapeutic administration of MSCs is typically into tissues

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service